Published September 24, 2024
| Version v1
Journal article
Open
HPMC-based fast-dissolving oral films with galantamine-loaded chitosan nanoparticles
Authors/Creators
- 1. Medical University of Sofia, Sofia, Bulgaria
Description
Alzheimer's disease is a brain disorder characterized by a gradual decline in memory, thinking, behavior, and social skills. Galantamine hydrobromide is a reversible competitive cholinesterase inhibitor used for managing Alzheimer's disease. Its oral administration, however, is accompanied by unwanted side effects, such as gastrointestinal disturbances, nausea, and vomiting. These side effects could be avoided by the incorporation of galantamine into nanoparticles. The present study describes the preparation and characterization of HPMC-based fast-dissolving oral films with galantamine-loaded chitosan nanoparticles. Galantamine-loaded chitosan nanoparticles were prepared using the ionotropic gelation method. High values for loading efficiency were established. DLS was used to evaluate the particle size and the Z-potential. The polymer used in this study for the preparation of the fast-dissolving oral films was HPMC, and PEG 400 was used as a plasticizer. The quality of the prepared films was evaluated based on the following criteria: flexibility, spreading ability, adhesiveness, non-sticky and easily peeled, and appearance. The thickness, folding endurance, and disintegration times of the prepared films were determined. In vitro dissolution studies were conducted in order to establish the drug release rate from the films.
Files
PHAR_article_134376.pdf
Additional details
References
- Al-Mogherah AI, Ibrahim MA, Hassan MA (2020) Optimization and evaluation of venlafaxine hydrochloride fast dissolving oral films. Saudi Pharmaceutical Journal 28: 1374–1382. https://doi.org/10.1016/j.jsps.2020.09.001
- AnjiReddy K, Karpagam S (2017) Chitosan nanofilm and electrospun nanofiber for quick drug release in the treatment of Alzheimer's disease: in vitro and in vivo evaluation. International Journal of Biological Macromolecules 105: 131–142. https://doi.org/10.1016/j.ijbiomac.2017.07.021
- Bala R, Pawar P, Khanna S, Arora S (2013) Orally dissolving strips: A new approach to oral drug delivery system. International Journal of Pharmaceutical Investigation 3: 67–76. https://doi.org/10.4103/2230-973X.114897
- Bhattacharya S, Haertel C, Maelicke A, Montag D (2014) Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease. PloS ONE 9: e89454. https://doi.org/10.1371/journal.pone.0089454
- Bhyan B, Jangra S, Kaur M, Singh H (2011) Orally fast dissolving films: Innovations in formulation and technology. International Journal of Pharmaceutical Sciences Review and Research 9: 9–15. www.globalresearchonline.net
- Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer's disease: causes and treatment. Molecules 25(24): 5789. https://doi.org/10.3390/molecules25245789
- Cardelle-Cobas A, Madureira AR, Costa E, Barros R, Tavaria FK, Pintado ME (2015) Development of oral strips containing chitosan as active ingredient: a product for buccal health, International Journal of Polymer Materials and Polymer Biomaterials 64: 906–918. https://doi.org/10.1080/00914037.2015.1030661
- Chapdelaine AH, Zyck D, Dzija MJ (2002) Improved edible film formulations containing maltodextrin. European Patent Office Publ. of Application with search report EP20020756411. [09 Jul 2002]
- Dimitrov M, Dotcheva D, Lambov N (2004) Preparation and Characterization of Polyethylene Oxide Hydrogels with Cytisine. Acta Pharmaceutica Turcica 46(1): 49–54.
- Dimitrov M, Georgieva D, Ilieva S, Petkova V (2023) The era of digital pharmacy. 3D printing - realities and perspectives. Pharmacia 70(4): 1083–1092. https://doi.org/10.3897/pharmacia.70.e111731
- Dineley KT, Pandya AA, Yakel JL (2015) Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends in Pharmacological Sciences 36: 96–108. https://doi.org/10.1016/j.tips.2014.12.002
- Doseva VN, Shenkov SD, Br'chkov KhI, Baranovskij VYu, Dimitrov MV, Lambov NG (2002) Hydrogels based on poly(acrylic acid) and isophorone diisocyanate. Vysokomolekularnye Soedineniya. Ser.A Ser.B Ser. C - Kratkie Soobshcheniya 44(8): 1444–1449.
- Elkordy AA, Tan XN, Essa EA (2013) Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles. European Journal of Pharmacy and Biopharmacy 83: 203–223. https://doi.org/10.1016/j.ejpb.2012.08.004
- Georgieva D, Nikolova D, Vassileva E, Kostova B (2023) Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer's Disease Therapy. Pharmaceutics 15: 829. https://doi.org/10.3390/pharmaceutics15030829
- Ilieva S, Georgieva D, Petkova V, Dimitrov M (2023) Study and characterization of polyvinyl alcohol-based formulations for 3D printlets obtained via fused deposition modeling. Pharmaceutics 15(7): 1867. https://doi.org/10.3390/pharmaceutics15071867
- Inglis F (2002) The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. International Journal of Clinical Practice. Supplement 127: 45–46.
- Jin H, Zhao Z, Lan Q, Zhou H, Mai Z, Wang Y, Ding X, Zhang W, Pi J, Evans CE, Liu X (2021) Nasal delivery of hesperidin/chitosan nanoparticles suppresses cytokine storm syndrome in a mouse model of acute lung injury. Frontiers in Pharmacology 11: 592238. https://doi.org/10.3389/fphar.2020.592238
- Kulkarni AS, Deokule HA, Mane MS, Ghadge DM (2010) Exploration of different polymers for use in the formulation of oral fast dissolving strips. Journal of Current Pharmaceutical Research 2: 33–35.
- Liu S, Yang S, Ho PC (2018) Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain. Asian Journal of Pharmaceutical Sciences 13: 72–81. https://doi.org/10.1016/j.ajps.2017.09.001
- Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396: 413–446. https://doi.org/10.1016/S0140-6736(20)30367-6
- Nikunj B, Kinjal S, Upendra P, Bhavesh P, Dipen P (2011) A review on fast dissolving film. International Journal of Pharmaceutical Research and Bio Sciences 1930: 66–89.
- Siddiqui N, Garg G, Sharma PK (2011) A short review on novel approach in oral fast dissolving drug delivery system and their patents. Advances in Biological Research 5(6): 291–303.
- Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in alzheimer disease: An update. Journal of Central Nervous System Disease 12: 1179573520907397. https://doi.org/10.1177/1179573520907397
- Qin Z, Jia XW, Liu Q, Kong B, Wang H (2019) Fast dissolving oral films for drug delivery prepared from chitosan/pullulan electrospinning nanofibers. International Journal of Biological Macromolecules 137: 224–231. https://doi.org/10.1016/j.ijbiomac.2019.06.224